Purpose

This study is a research trial of an outpatient, non-medication, non-invasive investigational treatment called Transcranial Magnetic Stimulation (TMS). TMS applies a magnetic field to the brain for a brief period of time. TMS is a procedure that involves 30 minute-long daily sessions every weekday for a series of weeks. We are testing whether TMS can treat depersonalization disorder.

Type of Study: Clinical Trial
Setting of Study: outpatient
Clinical Trials.gov number: NCT00529217
Providing Clinical Treatment?: Yes
No Cost Treatment?: Yes

Study Activities

Filling Out Forms
Blood Samples
Psychophysiology measurements

Eligibility

Ages Eligible for Study: 18 Years - 70 Years
Genders Eligible for Study: Both
This study is not recruiting Healthy Volunteers.

Criteria

Inclusion Criteria:
Primary diagnosis of Depersonalization Disorder.
Duration of the index episode of at least a year. Patients currently on DPD medication must be
at the same stable dose at least 2 months.


Links
Study summary on Division of Brain Stimulation and Therapeutic Modulation web site
Division of Brain Stimulation and Therapeutic Modulation home page

Location: Unit 21, 1051 Riverside Drive, New York, NY 10032
Clinic: 
Division: Other

Study chairs or principal investigators:
Antonio Mantovani MD, Principal Investigator

Co-investigators:
Daphne Simeon,
Sarah Lisanby,
Alex Sporn,
Arielle Stanford,
Peter Bulow